Attovia Therapeutics is pursuing a U.S. IPO to fund its immune-mediated disease drug pipeline, led by ATTO-1310. Learn more ...
Diskuze o tom, jak moc je Evropa závislá na čínských dodávkách, probíhá už dlouho. Vzácné zeminy, baterie pro elektromobily, ...
By Maggie Fick LONDON, July 24 (Reuters) - AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The company ...